Lv1
18 积分 2025-10-13 加入
Construction and evaluation of PSMA and integrin α2β1 targeted hetero-bivalent agents for the PET imaging and internal irradiation therapy of prostate cancer
2个月前
已完结
Radioligand therapy in combination with CAR T cells overcomes the heterogeneous immunosuppressive prostate tumor microenvironment
2个月前
已关闭
Ultra-low-dose radioimmunotherapy improves prostate cancer treatment efficacy and safety
3个月前
已完结
Initial Results of FAPI PET/MRI to Assess the Extent of Endometriosis
3个月前
已关闭
Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine Tool
3个月前
已关闭
Diagnostic Value of Routine Delayed Pelvic Imaging for Patients with Biochemical Recurrence of Prostate Cancer Undergoing 68 Ga-PSMA PET/CT
3个月前
已关闭
Role of 18 F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy
3个月前
已关闭
Anti-SV2C single domain nanobodies for molecular imaging in androgen receptor positive prostate cancer
4个月前
已完结
[68Ga]Ga-PSMA-617 PET/MRI for imaging patients suspected of hepatocellular carcinoma
5个月前
已完结
Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia
5个月前
已完结
皖公网安备34019202002308
